[Polo like kinase 1 expression and prognostic value in gastric carcinomas]
- PMID: 17253180
[Polo like kinase 1 expression and prognostic value in gastric carcinomas]
Abstract
Objective: To identify the expression of polo like kinase 1 (plk1) and to discuss its relationship with the clinicopathological parameters and prognosis in gastric carcinoma.
Methods: Plk1 protein expression levels in 89 cases of resected gastric carcinomas were detected by immunohistochemistry method, the relations between plk1 expression levels and the survival periods were estimated by Kaplan-Meier curve.
Results: The positive rate of plk1 expression in gastric cancer tissues was 42.7% (38/89), significantly higher than that (13.5%) in the adjacent noncancerous tissues (12/89) (P<0.01). The expression levels of plk1 were closely related to tumor differentiation, invasion and TNM stage (P<0.05). Patients with plk1-positive expression had worse prognosis than those with plk1-negative expression in gastric cancer patients (P<0.05).
Conclusions: Plk1 may promote carcinogenesis and gastric cancer development, its overexpression can be a novel marker for diagnosing certain biological behaviours and predicting prognosis in gastric cancer.
Similar articles
-
Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.Int J Oncol. 2006 Sep;29(3):589-94. Int J Oncol. 2006. PMID: 16865274
-
[Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].Zhonghua Wai Ke Za Zhi. 2007 Oct 1;45(19):1354-8. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18241575 Chinese.
-
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.Oncology. 2006;70(2):126-33. doi: 10.1159/000093003. Epub 2006 Apr 26. Oncology. 2006. PMID: 16645325
-
Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.Gene. 2019 Dec 30;721:144097. doi: 10.1016/j.gene.2019.144097. Epub 2019 Sep 4. Gene. 2019. PMID: 31493507
-
Polo-like kinases (Plks) and cancer.Oncogene. 2005 Jan 10;24(2):287-91. doi: 10.1038/sj.onc.1208272. Oncogene. 2005. PMID: 15640844 Review.
Cited by
-
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.Biosci Rep. 2017 Aug 31;37(4):BSR20170852. doi: 10.1042/BSR20170852. Epub 2017 Jul 19. Biosci Rep. 2017. PMID: 28724602 Free PMC article.
-
Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer.Cells. 2021 May 12;10(5):1176. doi: 10.3390/cells10051176. Cells. 2021. PMID: 34065956 Free PMC article. Review.
-
The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.Oncotarget. 2017 Sep 30;8(54):92497-92521. doi: 10.18632/oncotarget.21438. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190933 Free PMC article.
-
PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9.Exp Ther Med. 2012 Dec;4(6):1005-1009. doi: 10.3892/etm.2012.729. Epub 2012 Sep 28. Exp Ther Med. 2012. PMID: 23226764 Free PMC article.
-
Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820935531. doi: 10.1177/1533033820935531. Technol Cancer Res Treat. 2020. PMID: 32715931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous